HK1080724A1 - Stabilized pharmaceutical composition in lyophilized form - Google Patents

Stabilized pharmaceutical composition in lyophilized form

Info

Publication number
HK1080724A1
HK1080724A1 HK06100611A HK06100611A HK1080724A1 HK 1080724 A1 HK1080724 A1 HK 1080724A1 HK 06100611 A HK06100611 A HK 06100611A HK 06100611 A HK06100611 A HK 06100611A HK 1080724 A1 HK1080724 A1 HK 1080724A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical composition
lyophilized form
stabilized pharmaceutical
stabilized
lyophilized
Prior art date
Application number
HK06100611A
Other languages
English (en)
Inventor
Seiji Sawai
Akihiro Kasai
Kazumi Otomo
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16210881&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1080724(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of HK1080724A1 publication Critical patent/HK1080724A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
HK06100611A 1999-07-01 2006-01-13 Stabilized pharmaceutical composition in lyophilized form HK1080724A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18771399 1999-07-01

Publications (1)

Publication Number Publication Date
HK1080724A1 true HK1080724A1 (en) 2006-05-04

Family

ID=16210881

Family Applications (2)

Application Number Title Priority Date Filing Date
HK02101689.2A HK1040057B (zh) 1999-07-01 2002-03-05 凍幹形式的穩定的藥用組合物
HK06100611A HK1080724A1 (en) 1999-07-01 2006-01-13 Stabilized pharmaceutical composition in lyophilized form

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK02101689.2A HK1040057B (zh) 1999-07-01 2002-03-05 凍幹形式的穩定的藥用組合物

Country Status (28)

Country Link
US (2) US6774104B1 (xx)
EP (1) EP1107777B1 (xx)
JP (2) JP3381722B2 (xx)
KR (1) KR100454784B1 (xx)
CN (2) CN100352495C (xx)
AR (1) AR024634A1 (xx)
AT (1) ATE280583T1 (xx)
AU (1) AU752265B2 (xx)
BR (2) BR0006823A (xx)
CA (1) CA2341568C (xx)
CZ (1) CZ295720B6 (xx)
DE (1) DE60015279T2 (xx)
ES (1) ES2225161T3 (xx)
HK (2) HK1040057B (xx)
HU (1) HU229089B1 (xx)
ID (1) ID29468A (xx)
IL (2) IL141455A0 (xx)
MX (1) MXPA01000601A (xx)
NO (1) NO330353B1 (xx)
NZ (1) NZ510290A (xx)
OA (1) OA11601A (xx)
PL (1) PL200141B1 (xx)
PT (1) PT1107777E (xx)
RU (1) RU2251411C2 (xx)
TR (1) TR200100609T1 (xx)
TW (1) TWI233805B (xx)
WO (1) WO2001002002A1 (xx)
ZA (1) ZA200101589B (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
ITMI20021040A1 (it) * 2002-05-16 2003-11-17 Novuspharma Spa Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale
CN1293880C (zh) * 2002-07-31 2007-01-10 千寿制药株式会社 水性液体制剂和光稳定的水性液体制剂
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
WO2004045637A1 (en) * 2002-11-18 2004-06-03 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
EP1721610B1 (en) 2004-03-04 2009-05-13 Eisai R&D Management Co., Ltd. Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
WO2005111033A2 (en) * 2004-05-19 2005-11-24 Neurosearch A/S Novel azabicyclic aryl derivatives
WO2006053383A1 (en) * 2004-11-22 2006-05-26 Anadis Ltd Bioactive compositions
KR101307999B1 (ko) * 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
CA2614592A1 (en) * 2005-07-20 2007-01-25 Kyowa Medex Co., Ltd. Method for stabilization of peptides in a biological sample
CN1962852B (zh) * 2006-11-27 2011-11-09 西北农林科技大学 红景天多糖在制备抗冻剂中的新用途及其产品和制备方法
CN102614492B (zh) * 2011-01-31 2013-12-11 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂米卡芬净的液体药用组合物
CN102614491B (zh) 2011-01-31 2014-04-16 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂米卡芬净的药用组合物及其制备方法和用途
MX368854B (es) * 2012-05-22 2019-10-18 Paion Uk Ltd Composiciones que comprenden benzodiazepinas de acción corta.
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
CN103330932B (zh) * 2013-04-26 2015-12-23 江苏豪森药业股份有限公司 一种米卡芬净或其盐的药物组合物
CN103330933B (zh) * 2013-04-26 2015-08-05 江苏豪森药业股份有限公司 含有米卡芬净或其盐的药物组合物
PL3003298T3 (pl) * 2013-06-05 2024-07-15 The University Of British Columbia Związki antyfibrogenne, sposoby ich zastosowania
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
KR101611349B1 (ko) 2014-04-14 2016-04-12 신우철 안정성이 개선된 밀크씨슬 엑스의 제형
EP3150621A4 (en) * 2014-05-29 2017-12-27 Shanghai Techwell Biopharmaceutical Co., Ltd Composition of cyclic peptide compound, preparation method for same, and uses thereof
JP6779787B2 (ja) * 2014-12-05 2020-11-04 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 ジアザビシクロオクタン誘導体の結晶及び安定な凍結乾燥製剤の製造法
WO2016107890A1 (en) 2014-12-31 2016-07-07 Galenicum Health S.L. Stable pharmaceutical compositions comprising micafungin
EP3058958B1 (en) 2015-02-23 2018-09-19 Selectchemie AG Anidulafungin composition
WO2018112330A1 (en) 2016-12-16 2018-06-21 Baxter International Inc. Micafungin compositions
US11185527B2 (en) 2017-06-26 2021-11-30 Wayne State University Methods and compositions relating to steroid hormone receptor-dependent cancers
RU2666148C1 (ru) * 2017-10-05 2018-09-06 Общество с ограниченной ответственностью "Новые Антибиотики" Способ получения водорастворимой лиофилизированной формы соли бис(2-тио-4,6-диоксо-1,2,3,4,5,6-гексагидропиримидин-5-ил)-(4-нитрофенил)метана
EP3485873A1 (en) 2017-11-17 2019-05-22 Cadila Healthcare Limited Stable pharmaceutical injectable compositions of micafungin

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03193735A (ja) 1989-12-22 1991-08-23 Shionogi & Co Ltd グリコペプチド系抗生物質の安定化組成物
JPH03240727A (ja) 1990-02-15 1991-10-28 Toyo Jozo Co Ltd ニューモシスチス・カリニ肺炎治療剤
FI912873A (fi) * 1990-06-18 1991-12-19 Fujisawa Pharmaceutical Co Ny polypeptidfoerening och foerfarande foer dess framstaellning.
JP3193735B2 (ja) 1991-07-24 2001-07-30 株式会社リコー カラー画像形成装置の搬送装置
JPH0651641A (ja) 1992-07-30 1994-02-25 Olympus Optical Co Ltd 湿式現像装置
JPH06172204A (ja) * 1992-12-09 1994-06-21 Asahi Chem Ind Co Ltd アクレアシン類含有リポソーム製剤およびその製造法
JP3240727B2 (ja) 1993-02-25 2001-12-25 ソニー株式会社 偏平型陰極線管の画像歪補正装置
IL109615A (en) * 1993-05-17 2000-12-06 Fujisawa Pharmaceutical Co Cyclic polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
RU2165423C2 (ru) 1994-10-07 2001-04-20 Фудзисава Фармасьютикал Ко., Лтд. Полипептидное соединение, способ его получения и фармацевтическая композиция
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
CN1161462C (zh) * 1996-03-08 2004-08-11 藤泽药品工业株式会社 环脂肽物的脱酰化方法
AR006598A1 (es) * 1996-04-19 1999-09-08 Merck Sharp & Dohme "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
JPH09301997A (ja) 1996-05-17 1997-11-25 Yamanouchi Pharmaceut Co Ltd 新規環状ペプチド系化合物
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
FR2755857B1 (fr) * 1996-11-19 1998-12-24 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
AUPO381496A0 (en) * 1996-11-25 1996-12-19 Fujisawa Pharmaceutical Co., Ltd. New compound
JPH10279498A (ja) * 1997-04-07 1998-10-20 Nippon Shinyaku Co Ltd 慢性関節リウマチ治療剤
JP3544847B2 (ja) * 1998-01-16 2004-07-21 三菱電機株式会社 光学的情報再生方法および装置
EP1156782B1 (en) * 1999-03-03 2005-05-04 Eli Lilly And Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
JP2002538097A (ja) * 1999-03-03 2002-11-12 イーライ リリー アンド カンパニー 薬学的経口ｅｃｂ処方物および組成物の作製方法
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent

Also Published As

Publication number Publication date
AU5572200A (en) 2001-01-22
EP1107777A1 (en) 2001-06-20
DE60015279D1 (de) 2004-12-02
KR100454784B1 (ko) 2004-11-05
CZ295720B6 (cs) 2005-10-12
IL141455A0 (en) 2002-03-10
HK1040057A1 (en) 2002-05-24
HUP0103740A2 (hu) 2002-02-28
CN1636591A (zh) 2005-07-13
US6774104B1 (en) 2004-08-10
EP1107777B1 (en) 2004-10-27
KR20010072903A (ko) 2001-07-31
BRPI0006823B1 (pt) 2020-01-07
CA2341568A1 (en) 2001-01-11
JP2003503462A (ja) 2003-01-28
NZ510290A (en) 2003-07-25
PL346297A1 (en) 2002-01-28
TR200100609T1 (tr) 2001-07-23
US20040157769A1 (en) 2004-08-12
HU229089B1 (en) 2013-07-29
JP2002363097A (ja) 2002-12-18
IL141455A (en) 2006-12-31
WO2001002002A1 (en) 2001-01-11
CN100352495C (zh) 2007-12-05
PT1107777E (pt) 2005-01-31
HK1040057B (zh) 2005-08-05
AU752265B2 (en) 2002-09-12
NO20010893D0 (no) 2001-02-22
NO330353B1 (no) 2011-04-04
BRPI0006823B8 (pt) 2021-05-25
CZ20011186A3 (cs) 2001-09-12
CA2341568C (en) 2011-10-25
TWI233805B (en) 2005-06-11
CN1179748C (zh) 2004-12-15
RU2251411C2 (ru) 2005-05-10
AR024634A1 (es) 2002-10-16
CN1315865A (zh) 2001-10-03
OA11601A (en) 2004-07-30
MXPA01000601A (es) 2002-04-08
PL200141B1 (pl) 2008-12-31
ATE280583T1 (de) 2004-11-15
DE60015279T2 (de) 2005-05-25
ZA200101589B (en) 2002-09-02
JP3381722B2 (ja) 2003-03-04
BR0006823A (pt) 2001-06-05
JP4691866B2 (ja) 2011-06-01
US7112565B2 (en) 2006-09-26
ID29468A (id) 2001-08-30
HUP0103740A3 (en) 2002-08-28
NO20010893L (no) 2001-04-24
ES2225161T3 (es) 2005-03-16

Similar Documents

Publication Publication Date Title
HK1080724A1 (en) Stabilized pharmaceutical composition in lyophilized form
PL351387A1 (en) Pharmaceutical composition
HUP0202513A3 (en) Betha-carboline pharmaceutical compositions
GB0028088D0 (en) Pharmaceutical compositions
GB0001662D0 (en) Pharmaceutical compositions
PL354315A1 (en) Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides
PT1466615E (pt) Composição farmacêutica
GB9923436D0 (en) Pharmaceutical compositions
PL343769A1 (en) Pharmaceutical composition
GB9818591D0 (en) Pharmaceutical composition
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
GB9904163D0 (en) Pharmaceutical compositions
GB9911017D0 (en) Pharmaceutical compositions
IL131266A0 (en) Peptides and pharmaceutical compositions comprising same
EP1124557A4 (en) PHARMACEUTICAL COMPOSITION
GB9904911D0 (en) Pharmaceutical compositions
SI1189600T1 (en) Grf-containing lyophilized pharmaceutical compositions
GB9902651D0 (en) Pharmaceutical compositions
AU2002219514A1 (en) Stabilized pharmaceutical composition in lyophilized form
HU9800078D0 (en) Pharmaceutical composition
GB0015361D0 (en) Improvements in pharmaceutical compositions
GB9916413D0 (en) Pharmaceutical composition
GB9916210D0 (en) Pharmaceutical composition
GB9910671D0 (en) Improved pharmaceutical composition
GB9908636D0 (en) Novel pharmaceutical composition

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20200628